H. 970 - An Act to promote accessible substance abuse treatment for all.

In response to the serious opioid epidemic impacting all our communities, I have filed comprehensive legislation which proposes to:

  • Create patient choice through equal access to all medication assisted treatments.    It would require all private insurers, Medicaid and the Group Insurance Commission (GIC) to provide coverage for three clinically proven and FDA approved treatments:  methadone, buprenorphine (“Suboxone”), and naltrexone (“Vivitrol.”)
  • Direct Medicaid (MA Health), in consultation with the Department of Public Health (DPH) and the Health Policy Commission (HPC) to establish two primary care integration pilot programs for Medicaid patients seeking treatment for addiction at Opioid Treatment Centers.   This will facilitate the establishment of co-located medical homes by locating primary care practitioners within the same building at opioid treatment centers. 
  • Create a public, online consumer quality dashboard for substance abuse treatment providers.  This dashboard will provide those seeking substance abuse services information  about quality of substance abuse providers and how to access those providers.  The data is already collected by DPH but needs to be provided to the public.
  • Expand community walk-in centers for substance abuse services providing streamlined access to  services in a timely manner for consumers and providers.  This will be achieved through a central navigation model accounting for beds and services in real time.

H. 970 was heard by the Committee on Health Care Financing on June 24, 2015. 

Stay in touch with Garrett by signing up for email updates: Constituent Services Office Hours Contact Garrett